Grifols, S.A EBITDA 2012-2025 | GRFS

Grifols, S.A annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Grifols, S.A EBITDA for the quarter ending September 30, 2025 was $0.542B, a 41.16% increase year-over-year.
Grifols, S.A EBITDA for the twelve months ending September 30, 2025 was $1.792B, a 55.66% increase year-over-year.
Grifols, S.A 2024 annual EBITDA was $1.764B, a 31.28% increase from 2023.
Grifols, S.A 2023 annual EBITDA was $1.343B, a 5.07% increase from 2022.
Grifols, S.A 2022 annual EBITDA was $1.279B, a 13.18% increase from 2021.

Grifols, S.A Annual EBITDA (Millions of US $)
2024	$1,764
2023	$1,343
2022	$1,279
2021	$1,130
2020	$1,505
2019	$1,606
2018	$1,444
2017	$1,378
2016	$1,263
2015	$1,288
2014	$1,140
2013	$1,148
2012	$1,015
2011	$577

Grifols, S.A Quarterly EBITDA (Millions of US $)
2025-09-30	$542
2025-06-30	$527
2025-03-31	$401
2024-06-30	$322
2023-06-30	$384
2023-03-31	$183
2022-06-30	$282
2021-06-30	$302
2019-06-30	$356
2018-06-30	$312
2017-06-30	$374
2017-03-31	$326
2016-12-31	$322
2016-09-30	$322
2016-06-30	$308
2016-03-31	$312
2015-12-31	$333
2015-09-30	$330
2015-06-30	$309
2015-03-31	$313
2014-12-31	$171
2014-09-30	$159
2014-06-30	$298
2014-03-31	$388
2013-12-31	$251
2013-09-30	$291
2013-06-30	$309
2013-03-31	$289
2012-12-31	$232
2012-09-30	$255
2012-06-30	$256
2012-03-31	$255
2011-12-31	$796
2011-09-30	$807

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$6.442B	$7.805B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.187B	33.88
Zoetis (ZTS)	United States	$56.043B	20.06
Takeda Pharmaceutical (TAK)	Japan	$51.898B	10.59
Daiichi Sankyo, - (DSNKY)	Japan	$43.551B	21.69
BeOne Medicines - (ONC)	Switzerland	$37.054B	196.45
Sandoz Group AG (SDZNY)	Switzerland	$33.348B	0.00
United Therapeutics (UTHR)	United States	$20.806B	18.31
Merck (MKKGY)	Germany	$19.348B	11.93
Shionogi (SGIOY)	Japan	$15.738B	14.45
Summit Therapeutics (SMMT)	United States	$15.176B	0.00
Neurocrine Biosciences (NBIX)	United States	$13.539B	32.49
Ionis Pharmaceuticals (IONS)	United States	$13.007B	0.00
IPSEN (IPSEY)	France	$12.338B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.675B	0.00
Orion OYJ (ORINY)	Finland	$11.045B	31.56
Eisai (ESAIY)		$8.854B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Stevanato Group S.p.A (STVN)	Italy	$6.378B	35.69
Crinetics Pharmaceuticals (CRNX)	United States	$5.053B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.431B	18.08
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.074B	19.34
Corcept Therapeutics (CORT)	United States	$3.945B	42.61
NewAmsterdam Pharma (NAMS)	Netherlands	$3.897B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.014B	0.00
Hypermarcas (HYPMY)	Brazil	$2.914B	20.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.793B	8.91
Dyne Therapeutics (DYN)	United States	$2.538B	0.00
Ocular Therapeutix (OCUL)	United States	$2.399B	0.00
Soleno Therapeutics (SLNO)	United States	$2.310B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.997B	23.67
Guardian Pharmacy Services (GRDN)	United States	$1.920B	36.98
Ardelyx (ARDX)	United States	$1.881B	0.00
Harrow (HROW)	United States	$1.733B	106.32
BioCryst Pharmaceuticals (BCRX)	United States	$1.559B	92.50
Enliven Therapeutics (ELVN)	United States	$1.543B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.440B	7.13
Relay Therapeutics (RLAY)	United States	$1.385B	0.00
Oruka Therapeutics (ORKA)	United States	$1.349B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.341B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.316B	0.00
Evotec AG (EVO)	Germany	$1.300B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.291B	0.00
Savara (SVRA)	United States	$1.182B	0.00
Cronos Group (CRON)	Canada	$1.025B	0.00
Xencor (XNCR)	United States	$0.992B	0.00
Theravance Biopharma (TBPH)	United States	$0.965B	40.51
Esperion Therapeutics (ESPR)	United States	$0.928B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.849B	0.00
Nektar Therapeutics (NKTR)	United States	$0.808B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.769B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.741B	6.62
ProKidney (PROK)	United States	$0.704B	0.00
Bioventus (BVS)	United States	$0.665B	13.61
Ironwood Pharmaceuticals (IRWD)	United States	$0.660B	15.61
Organogenesis (ORGO)	United States	$0.534B	0.00
Lyell Immunopharma (LYEL)	United States	$0.522B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.521B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.478B	0.00
Aquestive Therapeutics (AQST)	United States	$0.477B	0.00
Siga Technologies (SIGA)	United States	$0.473B	6.48
4D Molecular Therapeutics (FDMT)	United States	$0.429B	0.00
Altimmune (ALT)	United States	$0.419B	0.00
Akebia Therapeutics (AKBA)	United States	$0.403B	0.00
Nature's Sunshine Products (NATR)	United States	$0.380B	22.64
USANA Health Sciences (USNA)	United States	$0.363B	10.13
Relmada Therapeutics (RLMD)	United States	$0.316B	0.00
Avalo Therapeutics (AVTX)	United States	$0.314B	0.00
Profound Medical (PROF)	Canada	$0.306B	0.00
Protara Therapeutics (TARA)	United States	$0.297B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.296B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.286B	0.00
Larimar Therapeutics (LRMR)	United States	$0.276B	0.00
OmniAb (OABI)	United States	$0.275B	0.00
Fractyl Health (GUTS)	United States	$0.274B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.261B	0.00
Heron Therapeutics (HRTX)	United States	$0.255B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.247B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.214B	0.00
MediWound (MDWD)	Israel	$0.207B	0.00
Galectin Therapeutics (GALT)	United States	$0.203B	0.00
Journey Medical (DERM)	United States	$0.197B	0.00
Minerva Neurosciences (NERV)	United States	$0.193B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.188B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.170B	0.00
Prelude Therapeutics (PRLD)	United States	$0.165B	0.00
VAXART, INC (VXRT)	United States	$0.164B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
AleAnna (ANNA)	United States	$0.160B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.159B	0.00
Surrozen (SRZN)	United States	$0.158B	0.00
Context Therapeutics (CNTX)	United States	$0.148B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.146B	0.00
Incannex Healthcare (IXHL)	Australia	$0.137B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.133B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.129B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.127B	0.00
Pyxis Oncology (PYXS)	United States	$0.110B	0.00
Avita Medical (RCEL)	United States	$0.104B	0.00
Cassava Sciences (SAVA)	United States	$0.101B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.099B	0.00
Vivani Medical (VANI)	United States	$0.097B	0.00
Champions Oncology (CSBR)	United States	$0.094B	39.88
Korro Bio (KRRO)	United States	$0.089B	0.00
Gain Therapeutics (GANX)	United States	$0.089B	0.00
Plus Therapeutics (PSTV)	United States	$0.076B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.074B	61.88
PolyPid (PYPD)	Israel	$0.074B	0.00
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Metagenomi (MGX)	United States	$0.067B	0.00
Rafael Holdings (RFL)	United States	$0.066B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.066B	0.00
Arch Biopartners (ACHFF)	Canada	$0.064B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.063B	0.00
Assertio Holdings (ASRT)	United States	$0.059B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.055B	0.00
Lite Strategy (LITS)	United States	$0.054B	0.00
Nutriband (NTRB)	United States	$0.053B	0.00
Talphera (TLPH)	United States	$0.049B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.047B	0.00
ElectroCore (ECOR)	United States	$0.045B	0.00
Lipocine (LPCN)	United States	$0.044B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.039B	0.00
FibroGen (KYNB)	United States	$0.037B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Wellgistics Health (WGRX)	United States	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.033B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
Natural Alternatives (NAII)	United States	$0.028B	0.00
TherapeuticsMD (TXMD)	United States	$0.025B	0.00
Klotho Neurosciences (KLTO)	United States	$0.025B	0.00
Scienture Holdings (SCNX)	United States	$0.023B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.018B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.017B	0.00
Mannatech (MTEX)	United States	$0.015B	0.00
Tempest Therapeutics (TPST)	United States	$0.014B	0.00
CASI Pharmaceuticals (CASI)	China	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Mangoceuticals (MGRX)	United States	$0.011B	0.00
Traws Pharma (TRAW)	United States	$0.011B	0.01
Curanex Pharmaceuticals Inc (CURX)	United States	$0.011B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Lyra Therapeutics (LYRA)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Salarius Pharmaceuticals (DCOY)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Jaguar Animal Health (JAGX)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00